PT2849798T - Composições de complexo quelato de oligonucleótidos-polipéptido e métodos - Google Patents
Composições de complexo quelato de oligonucleótidos-polipéptido e métodosInfo
- Publication number
- PT2849798T PT2849798T PT137916185T PT13791618T PT2849798T PT 2849798 T PT2849798 T PT 2849798T PT 137916185 T PT137916185 T PT 137916185T PT 13791618 T PT13791618 T PT 13791618T PT 2849798 T PT2849798 T PT 2849798T
- Authority
- PT
- Portugal
- Prior art keywords
- methods
- chelate complex
- polypeptide compositions
- oligonucleotide chelate
- oligonucleotide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261648711P | 2012-05-18 | 2012-05-18 | |
| US201261695035P | 2012-08-30 | 2012-08-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2849798T true PT2849798T (pt) | 2021-05-18 |
Family
ID=49581470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT137916185T PT2849798T (pt) | 2012-05-18 | 2013-05-17 | Composições de complexo quelato de oligonucleótidos-polipéptido e métodos |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US9492506B2 (pt) |
| EP (1) | EP2849798B1 (pt) |
| JP (1) | JP2015517504A (pt) |
| KR (1) | KR102068109B1 (pt) |
| CN (1) | CN104349793B (pt) |
| AU (1) | AU2013262416B2 (pt) |
| BR (1) | BR112014028654A2 (pt) |
| CA (1) | CA2873529C (pt) |
| CL (1) | CL2014003134A1 (pt) |
| CO (1) | CO7131387A2 (pt) |
| CR (1) | CR20140527A (pt) |
| CY (1) | CY1124345T1 (pt) |
| DK (1) | DK2849798T3 (pt) |
| DO (1) | DOP2014000264A (pt) |
| EA (1) | EA035967B1 (pt) |
| EC (1) | ECSP14027694A (pt) |
| ES (1) | ES2873844T3 (pt) |
| HK (1) | HK1204279A1 (pt) |
| HR (1) | HRP20210840T1 (pt) |
| HU (1) | HUE054875T2 (pt) |
| IL (1) | IL235548B (pt) |
| LT (1) | LT2849798T (pt) |
| MX (1) | MX346239B (pt) |
| MY (1) | MY168778A (pt) |
| NZ (1) | NZ703095A (pt) |
| PH (1) | PH12014502551A1 (pt) |
| PL (1) | PL2849798T3 (pt) |
| PT (1) | PT2849798T (pt) |
| RS (1) | RS62030B1 (pt) |
| SG (1) | SG11201407599SA (pt) |
| SI (1) | SI2849798T1 (pt) |
| TW (1) | TWI635864B (pt) |
| WO (1) | WO2013170386A1 (pt) |
| ZA (1) | ZA201408674B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7943591B2 (en) | 2007-05-11 | 2011-05-17 | Adynxx, Inc. | Gene expression and pain |
| PT2846839T (pt) | 2012-05-10 | 2019-05-29 | Adynxx Inc | Formulações para a administração de ingredientes ativos |
| NZ705730A (en) | 2012-08-30 | 2016-06-24 | Replicor Inc | Methods for the treatment of hepatitis b and hepatitis d infections |
| HRP20231400T1 (hr) * | 2014-07-10 | 2024-02-16 | Replicor Inc. | Kelirani fosforotioirani polimeri nukleinskih kiselina, namijenjeni upotrebi u kombinaciji s inhibitorom hbv polimeraze u liječenju infekcija virusima hepatitisa b i hepatitisa d |
| US10287583B2 (en) | 2014-08-15 | 2019-05-14 | Adynxx, Inc. | Oligonucleotide decoys for the treatment of pain |
| US11166976B2 (en) | 2018-11-08 | 2021-11-09 | Aligos Therapeutics, Inc. | S-antigen transport inhibiting oligonucleotide polymers and methods |
| PE20211783A1 (es) * | 2018-11-08 | 2021-09-08 | Aligos Therapeutics Inc | Polimeros oligonucleotidos que inhiben el transporte de antigenos y metodos |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2769114B2 (ja) * | 1993-10-29 | 1998-06-25 | サイクローン・ファーマシューティカルズ | ミニマルｂ型肝炎感染症治療用医薬組成物 |
| UA78726C2 (en) * | 2001-11-01 | 2007-04-25 | Sciclone Pharmaceuticals Inc | Pharmaceutical composition of thymosin alpha 1 conjugated with polyethylene glycol, method for production, and method for treatment |
| EP2330194A3 (en) * | 2002-09-13 | 2011-10-12 | Replicor, Inc. | Non-sequence complementary antiviral oligonucleotides |
| JP2006519235A (ja) * | 2003-02-26 | 2006-08-24 | インターミューン インコーポレイティッド | ポリエチレングリコール修飾インターフェロン組成物およびその使用方法 |
| DE602004018363D1 (de) * | 2003-10-27 | 2009-01-22 | Vertex Pharma | Kombinationen für die hcv-behandlung |
| AU2005297376A1 (en) * | 2004-10-19 | 2006-04-27 | Replicor Inc. | Antiviral oligonucleotides |
| WO2007022642A2 (en) * | 2005-08-25 | 2007-03-01 | Replicor Inc. | Anti-inflammatory molecules and their uses |
| CA2624686A1 (en) * | 2005-09-29 | 2007-04-05 | Replicor Inc. | Therapeutic molecules and their uses |
| US7776818B2 (en) * | 2005-09-29 | 2010-08-17 | S-Cell Biosciences, Inc. | Methods to treat T-cell disorders using TISF |
| GB0715383D0 (en) * | 2007-08-08 | 2007-09-19 | Asterion Ltd | Interferon |
| WO2009065181A1 (en) * | 2007-11-21 | 2009-05-28 | Apollo Life Sciences Limited | Nanostructures suitable for delivery of agents |
| WO2009076679A2 (en) | 2007-12-13 | 2009-06-18 | Alnylam Pharmaceuticals Inc. | Methods and compositions for prevention or treatment of rsv infection |
| AU2009221064B2 (en) * | 2008-03-07 | 2014-12-11 | Roche Innovation Center Copenhagen A/S | Pharmaceutical compositions for treatment of microRNA related diseases |
| JP5960049B2 (ja) * | 2009-05-28 | 2016-08-02 | クルナ・インコーポレーテッド | 抗ウイルス遺伝子に対する天然アンチセンス転写物の抑制による抗ウイルス遺伝子関連疾患の治療 |
| BR112012008865A2 (pt) * | 2009-10-16 | 2019-09-24 | Glaxo Group Ltd | inibidores de hbv anti-sentido. |
| HUE029521T2 (en) * | 2010-08-20 | 2017-03-28 | Replicor Inc | Oligonucleotide chelate complexes |
| NZ705730A (en) | 2012-08-30 | 2016-06-24 | Replicor Inc | Methods for the treatment of hepatitis b and hepatitis d infections |
-
2013
- 2013-05-17 US US13/896,510 patent/US9492506B2/en active Active
- 2013-05-17 PT PT137916185T patent/PT2849798T/pt unknown
- 2013-05-17 SG SG11201407599SA patent/SG11201407599SA/en unknown
- 2013-05-17 HU HUE13791618A patent/HUE054875T2/hu unknown
- 2013-05-17 KR KR1020147035252A patent/KR102068109B1/ko active IP Right Grant
- 2013-05-17 MY MYPI2014003189A patent/MY168778A/en unknown
- 2013-05-17 WO PCT/CA2013/050379 patent/WO2013170386A1/en active Application Filing
- 2013-05-17 TW TW102117594A patent/TWI635864B/zh active
- 2013-05-17 LT LTEP13791618.5T patent/LT2849798T/lt unknown
- 2013-05-17 CA CA2873529A patent/CA2873529C/en active Active
- 2013-05-17 DK DK13791618.5T patent/DK2849798T3/da active
- 2013-05-17 EP EP13791618.5A patent/EP2849798B1/en active Active
- 2013-05-17 AU AU2013262416A patent/AU2013262416B2/en active Active
- 2013-05-17 MX MX2014014021A patent/MX346239B/es active IP Right Grant
- 2013-05-17 EA EA201401278A patent/EA035967B1/ru unknown
- 2013-05-17 PL PL13791618T patent/PL2849798T3/pl unknown
- 2013-05-17 JP JP2015511877A patent/JP2015517504A/ja active Pending
- 2013-05-17 SI SI201331881T patent/SI2849798T1/sl unknown
- 2013-05-17 ES ES13791618T patent/ES2873844T3/es active Active
- 2013-05-17 RS RS20210674A patent/RS62030B1/sr unknown
- 2013-05-17 CN CN201380026009.3A patent/CN104349793B/zh active Active
- 2013-05-17 BR BR112014028654A patent/BR112014028654A2/pt active Search and Examination
- 2013-05-17 NZ NZ703095A patent/NZ703095A/en unknown
-
2014
- 2014-11-06 IL IL235548A patent/IL235548B/en active IP Right Grant
- 2014-11-14 PH PH12014502551A patent/PH12014502551A1/en unknown
- 2014-11-18 CL CL2014003134A patent/CL2014003134A1/es unknown
- 2014-11-18 DO DO2014000264A patent/DOP2014000264A/es unknown
- 2014-11-18 CR CR20140527A patent/CR20140527A/es unknown
- 2014-11-18 EC ECIEPI201427694A patent/ECSP14027694A/es unknown
- 2014-11-19 CO CO14254322A patent/CO7131387A2/es unknown
- 2014-11-25 ZA ZA2014/08674A patent/ZA201408674B/en unknown
-
2015
- 2015-05-21 HK HK15104859.5A patent/HK1204279A1/xx unknown
-
2021
- 2021-05-26 HR HRP20210840TT patent/HRP20210840T1/hr unknown
- 2021-05-31 CY CY20211100467T patent/CY1124345T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2836212A4 (en) | NOVEL COMPOSITIONS AND METHOD | |
| ZA201408594B (en) | Xylitol-based anti-mucosal compositions and related methods and compositions | |
| HK1206259A1 (en) | Oligonucleotide chelate complex methods | |
| HK1216250A1 (zh) | '- '-羥基-二氫麥角胺化合物及組合物 | |
| ZA201408674B (en) | Oligonucleotide chelate complex-polypeptide compositions and methods | |
| EP2852602A4 (en) | COMPOSITIONS AND METHODS FOR CONJUGATING OLIGONUCLEOTIDES | |
| EP2804611A4 (en) | COMPOSITIONS FROM CHITOSAN | |
| GB201315350D0 (en) | Methods and compositions | |
| GB201315347D0 (en) | Methods and compositions | |
| EP2874641A4 (en) | COMPOSITIONS INCREASING THE GLUTATHION RATE AND USES THEREOF | |
| EP2879670A4 (en) | ANTIBACTERIAL COMPOSITIONS AND METHOD | |
| GB201210800D0 (en) | Compositions | |
| GB201201287D0 (en) | Compositions | |
| EP2931280A4 (en) | METHOD AND COMPOSITIONS FOR INHIBITING CNKSR1 | |
| ZA201308892B (en) | Compositions and methods | |
| EP2766357A4 (en) | MESOBILIVERDINE COMPOSITIONS AND METHOD THEREFOR | |
| EP2834635A4 (en) | COMPOSITIONS WITH A HEPARINE ACCUMULATIVE AND METHOD THEREFOR | |
| EP2926813A4 (en) | METFORMIN-Orlistat COMPOSITIONS | |
| GB201223148D0 (en) | Compositions | |
| GB201218959D0 (en) | Compositions | |
| GB201209187D0 (en) | Compositions | |
| GB201209189D0 (en) | Compositions | |
| GB201116340D0 (en) | Compositions and methods | |
| GB201204102D0 (en) | Compositions | |
| GB201203082D0 (en) | Compositions |